| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Lexeo Therapeutics, Inc. (LXEO) have been net sellers, shedding 8,766 shares worth roughly $43K on balance.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 376.8K | $1.17M | - | |
| COO | 138.3K | $430.1K | - | |
| CFO | 92.9K | $288.9K | - | |
| Other | 84.9K | $264.1K | - | |
| Other | 72.6K | $225.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2024 | Richard Nolan Townsend74 | Chief Executive Officer | Sale+OE10b5-1 | 5,000 | $11.53 | $57,634.50 | -4.0% | -33.6% | -61.0% | |
| Jul 11, 2024 | Richard Nolan Townsend74 | Chief Executive Officer | Sale+OE10b5-1 | 55,000 | $16.79 | $923,387.71 | -31.3% | -51.3% | -74.4% | |
| Jun 10, 2024 | Richard Nolan Townsend74 | Chief Executive Officer | Sale+OE10b5-1 | 5,000 | $17.65 | $88,263.82 | -2.8% | -42.2% | -75.4% | |
| May 13, 2024 | Richard Nolan Townsend74 | Chief Executive Officer | Sale+OE10b5-1 | 5,000 | $13.22 | $66,093.00 | -2.8% | -11.7% | -79.1% | |
| Nov 7, 2023 | Omega Fund VI, L.P. | 10% Owner | Buy | 454,545 | $11.00 | $4,999,995.00 | +26.7% | +61.6% | -21.6% | |
| Nov 7, 2023 | Invest A/s Lundbeckfond | 10% Owner | Buy | 227,272 | $11.00 | $2,499,992.00 | +14.1% | +61.6% | -21.6% | |
| Nov 7, 2023 | Longitude Capital Partners IV, LLC63 | 10% Owner | Buy | 454,545 | $11.00 | $4,999,995.00 | +21.5% | +61.6% | -21.6% |